Canon Announces New Biomedical Company
04 March 2015
Canon U.S.A announced on March 2, 2015 that it established Canon BioMedical to develop, manufacture, and market operations related to Canon’s life-science and molecular diagnostics platform. The company also plans to expand the use of Canon technology into other medical fields.
03 March 2015
Corporate venture capital isn’t new; companies like Intel, Siemens, Cisco and Johnson & Johnson have long had VC arms. But, as seemingly everything else in the venture realm, the number of active corporate VCs is quickly growing. In 2014, 166 different corporate VC investors completed at least one deal, a 73% increase from the 96 such investors in 2005.
Patent filings up in China: What does that mean for the biopharma sector?
03 March 2015
China has seen a massive rise in patent filings over the last seven years, with the number of published patents growing an average of 16 percent annually.
02 March 2015
Clearside Biomedical, Inc., a clinical-stage biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye, today announced the enrollment of the first patient in a Phase 2 randomized, controlled, masked, multi-center clinical trial for the treatment of macular edema associated with retinal vein occlusion (RVO) using Clearside’s proprietary formulation of triamcinolone acetonide, CLS-TA, administered via suprachoroidal (SCS) injection using Clearside’s proprietary microinjector.
Financial scorecard: biotech continues its great start
02 March 2015
As February moves into its final trading week the biotech sector continues to roll along, setting the pace for another strong year.
Is A Renaissance In Surging Biotechs Underway?
02 March 2015
Not too long ago, investing in biotechnology was perceived as plain gambling. The rewards could be high, to be sure, but so were the risks in playing the arcane biotech stocks.
Nobel winner Harald Zur Hausen on vaccines and the need for basic research
02 March 2015
Harald zur Hausen in 1976 published the hypothesis that human papillomavirus plays an important role in the cause of cervical cancer. It took three decades before that groundbreaking work led to approval of a vaccine for cervical cancer.
China says to implement drug distribution reforms
02 March 2015
China said on Saturday it would implement drug distribution reforms including centralisation measures designed to cut prices and reduce corruption.
Empowered patients want greater sway over industry and the FDA
02 March 2015
Consumers are frustrated with the pace of drug and medical device development, and they want more engagement with industry and regulators at every step of the process, from trial design to FDA review. Savvy biopharmas and medical device manufacturers would be wise to heed that call by incorporating input from patients at every stage of development and sharing that feedback with the FDA as part of regulatory filings.
WHO adopts new safety needle policy, calling smart syringes an 'urgent priority'
27 February 2015
Citing rampant use of the same needle to inject more than one person, the World Health Organization has--some might say finally--launched a new policy to make unsafe injections less prevalent. Part of this policy involves adopting up-to-date measures in syringe engineering, promoting the use of "smart" needles with precautions against unsafe use.
Merry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
A Moscow region manufacturer of blood collection systems is expanding its capacity
22 January 2025
A biotechnology and medicine center has opened in Mordovia
22 January 2025
Long-term potential revealed for novel modifier gene therapy
21 January 2025
Binnopharm Group opened an office in Vietnam
21 January 2025